We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.


Celprogen Launches Cancer Stem Cells

Want a FREE PDF version of This News Story?

Complete the form below and we will email you a PDF version of "Celprogen Launches Cancer Stem Cells"

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

Read time:

Celprogen Inc. has announced that they have successfully isolated and propagated 11 major cancer stem cells. These Cancer Stems were launched in May 2007 at the AACR meeting in Los Angeles and also in December 2007 at ASCB in Washington DC.

Celprogen’s cancer stem cells are available for basic science research and drug discovery. The cancer stem cells are as follows: Brain, Breast, Colon, Kidney, Leukemia, Liver, Lungs, Melanoma, Ovarian, and Pancreatic & Prostate.

Celprogen provides the Cancer Stem Cell Tissue culture system which includes cells, pre-coated flasks with extracellular matrix and Medium for growth and proliferation of these cells.